Abstract

A young AHA class I patient adult attended the Emergency Medicine Department of a Tertiary care center in a shocked state. This patient body mass index was twenty. He did not have any family history of heart disease.4 The patient also did not have any history of smoking, diabetes and hypertension. Idiopathic Ventricular tachycardia is common cause of morbidity in young patients where we do not encounter any structural heart problem1 The patient did not give any history of covid infection and he was vaccinated for covid. The patient attended the triage of a tertiary care hospital Emergency Department. He came walking to the hospital with complains of ghabhrahat and uneasiness. His peripheral pulses were not palpable. He was immediately made to lie down on a trolley and his ECG was done. His ECG Showed monomorphic Ventricular tachycardia. Patients of cardiac arrthymias attend the emergency departments quite frequently. The patient’s Blood pressure was not recordable and his carotids were feeble. Therefore, the option of cardioversion with drugs was not possible. Patient was cardioverted by electrical cardioversion and revived immediately. Increasing number of patients who survive the first attack of, arrhythmia if not started with anti-arrhythmic medication may develop life threatening fatal arrhythmia subsequently.

• 1.   Idiopathic Ventricular Tachycardia; Robert C. Ward1, Martinvan Zyl1, Christopher V. DeSimone1,*J Clin Med;. 2023 Jan 25; 12(3): 930. doi: 10.3390/jcm12030930.
• 2.   Marco Zuin1, Gianluca Rigatelli2, Valentina Battisti3, Giulia Costola3, Loris Roncon4, Claudio Bilato3 Increased risk of acute myocardial infarction after COVID-19 recovery: A systematic review and metaanalysis; Meta-Analysis; Int J Cardiol. 2023 Feb 1:372: 138-143.doi: 10.1016/j.ijcard.2022.12.032. Epub 2022 Dec 16.
• 3.   Julia Stowea, Heather J. Whitakera, Nick J. Andrewsa, Elizabeth Millerb Risk of cardiac arrhythmia and cardiac arrest after primary and booster COVID-19 vaccination in England: A self-controlled case series analysis; Vaccine: X; Volume 15, December 2023, 100418; https:// doi.org/10.1016/j.jvacx.2023.100418.
• 4.   Britt-Maria Beckmann1, Arne Pfeufer2, Stefan Kaab1,*; Inherited Cardiac Arrhythmias Diagnosis, Treatment, and Prevention; Dtsch Arztebl Int. 2011 Sep 16; 108(37): 623–634. doi: 10.3238/arztebl.2011.0623.
• 5.   Kiran Haresh Kumar Patel1, Rohin K Reddy1, ArunashisSau1, Pavidra Sivanandarajah1, Maddalena Ardissino1,2, FuSiong Ng Obesity as a risk factor for cardiac arrhythmias; BMJ Med. 2022 Oct 19; 1(1): e000308. doi: 10.1136/ bmjmed-2022-000308.
• 6.   H. Domanovits1, M. Paulis, M. Nikfardjam, M. Holzer, H.G. Stuhlinger, M.M. Hirschl, A.N. Laggner; Sustained ventricular tachycardia in the emergency department; Clinical Trial; Resuscitation. 1999 Sep; 42(1): 19-25.doi: 10.1016/s0300-9572(99)00044-1.
• 7.   Jason P. Causer1, Derek T. Connelly1 Implantable defibrillators for life threatening ventricular arrhythmias; Are more effective than antiarrhythmic drugs in selected high risk patients; BMJ. 1998 Sep 19; 317(7161): 762–763. doi: 10.1136/bmj.317.7161.762.
• 8.   Barbara J. Deal, M.D., Scott M. Miller, M.D., Daniel Scagliotti, M.D., Ventricular tachycardia In a young population without overt disease; Circulation; 1986 Jun.
• 9.   Foth C., Gangwani M.K., Ahmed I., et al. Ventricular Tachycardia. [Updated 2023 Jul 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/ NBK532954/.
• 10.   Gausche M., Persse D.E., Sugarman T., Shea S.R., Palmer G.L., Lewis R.J., Brueske P.J., Mahadevan S., Melio F.R., Kuwate J.H., et al. Adenosine for the prehospital treatment of paroxysmal supraventricular tachycardia. Ann Emerg Med. 1994 Aug; 24(2): 183-9. doi: 10.1016/s0196-0644(94)70128-8. PMID: 8037382.
• 11.   David P. Keseg, M.D., FACEP; Eric Cortez, MD Carla Cash, MD Raymond L. Fowler, MD, FACEP, FAEMS: Strategies for Pre hospital Treatment of Stable Ventricular Tachcardia: March 1.2018.
• 12.   Management of Cardiac arrest; Circulation; Volume 12, Number 24,November 2005.
• 13.   YangYang, NianchunPeng, GangChen, QinWan, LiYan; Interaction between smoking and diabetes in relation to subsequent risk of cardiovascular events; Cardiovascular Diabetologyvolume 21, Article number: 14 (2022).
• 14.   John R. Petrie1, Tomasz J. Guzik1, Rhian M Touyz1,*; Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms; Can J Cardiol. 2018 May; 34(5): 575–584. doi: 10.1016/j.cjca.2017.12.005.

Data Sharing Statement

Funding